Ls Investment Advisors, LLC Xencor Inc Transaction History

Ls Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$40.81 - $53.88 $197,397 - $260,617	-4,837 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$36.63 - $47.63 $177,179 - $230,386	4,837 New	4,837 $211,000
Q3 2020 Nov 12, 2020	SELL	$30.09 - $43.02 $51,905 - $74,209	-1,725 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$27.76 - $33.42 $4,219 - $5,079	152 Added 9.66%	1,725 $56,000
Q4 2019 Jan 31, 2020	SELL	$32.75 - $41.43 $113,806 - $143,969	-3,475 Reduced 68.84%	1,573 $54,000
Q3 2019 Oct 31, 2019	BUY	$33.73 - $46.27 $170,269 - $233,570	5,048 New	5,048 $170,000

216

71.8M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.53B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.